INTRODUCTION AND OBJECTIVES:
Few studies have examined the role of adjuvant radiation therapy (AXRT) in advanced penile squamous cell carcinoma. We sought to evaluate the association of pelvic AXRT with survival and recurrence for patients with penile cancer and positive pelvic lymph nodes (PLN) after lymph node dissection.
METHODS: Data were collected retrospectively across 4 international centers of patients with penile squamous cell carcinoma (PeCa) undergoing lymph node dissections from 1980 to 2013. 92 patients with positive PLN were analyzed. Variables recorded included age, stage, histological grade, PLN status, pelvic extranodal extension (ENE), chemotherapy status, disease-specific survival, overall survival, and recurrence.
RESULTS: 43% (n¼40) patients received AXRT after a positive PLN dissection. Median follow up was 9.3 months . The median number of positive PLN was 2 (IQR 1-3). Patients receiving AXRT had an improved median overall survival (OS) of 12.2 months versus 8 months in those who did not receive radiation (p¼0.0447). Median disease-specific survival (DSS) was 14.4 months versus 8 months in the AXRT and non-AXRT group respectively (p¼0.0232). Patients not receiving AXRT was associated with worse OS (HR: 1.9; 95% CI: 1.11-3.26; p¼0.0195) and DSS (HR: 2.08; 95% CI: 1.18-3.66; p¼0.0112) on multivariable analysis. Median time to recurrence was 7.7 months versus 5.3 months in the radiation and non-radiation arm respectively (p¼0.0425). Patients not receiving AXRT was also independently associated with higher overall recurrence on multivariable analysis (HR: 1.98; 95% CI: 1.15-3.42; p¼0.0131).
CONCLUSIONS: AXRT is associated with improved OS and DSS, and decreased recurrence in this population of PeCa patients with positive PLN. Further studies with a prospective design and larger data sets are required to validate this finding. METHODS: Patients treated at Fudan University Shanghai Cancer Center (n¼175) and Moffitt Cancer Center (n¼28) were used for prediction assessment and repetition, respectively. The ILN complexity score (ILCS) included 5 radiological features of ILNs and surrounding adipose tissue. A tertiary (low/moderate/high) classification was assigned according to the sum score. Postoperative complications were graded according to the Clavien-Dindo system. Logistic regression analyses were used to assess the odd ratios (ORs) of the ILCS for predicting overall and major (grade¼2) complications.
Source of
RESULTS: In the primary cohort, overall and major complications were observed in 47.4% and 20.5% of patients, respectively. Controlling for covariates, the moderate and high scores had 2.73 (p¼0.02) and 4.61-fold (p¼0.01) increased risks of overall complications compared with the low score. For predicting major complications, the adjusted OR was 3.48 for the moderate score (p¼0.02), and 17.01 for the high score (p<0.01), using the low score as a reference. The predictive accuracy of the ILCS for overall and major complications was 0.63 (0.56-0.70) and 0.73 (0.64-0.82), respectively. In the repetition cohort, the ILCS was significantly associated with major complications (OR¼17.33, p¼0.02) and showed a predictive accuracy of 0.79 (0.64-0.93).
CONCLUSIONS: Using structured radiological measurements of the inguinal nodal basin, the ILCS provided accurate risk estimation of overall and major complications after ILND for penile cancer. ILN) for high-risk, clinically node negative penile squamous cell carcinoma (SCC) due to the significant risk of ILNs harboring micrometastatic disease and significant survival advantage noted in those who undergo prophylactic ILN dissection. As penile SCC is rare in the US, we sought to use population-level data to determine adherence to guidelines, factors associated with adherence, and survival implications.
Source of Funding: none
METHODS: Starting in 2012, the National Cancer Database (NCDB) has reported on regional lymph node staging procedures. We queried the NCDB from 2012-2014 for all patients diagnosed with pT1b-T3, cN0 penile SCC who, by guidelines, should receive ILN sampling. Binomial logistic regression analysis was performed to determine predictors of ILN sampling. Variables included were facility type, geographic region, age, race, insurance status, income/education level of region, urban vs rural, patient distance from hospital, comorbidity, and pT-stage. Multivariate Cox regression analysis was performed for overall survival (OS) utilizing the aforementioned variables in addition to the performance of ILN staging.
RESULTS: Of the 765 pT1b-T3, cN0 penile SCC patients identified, only 28.2% underwent surgical staging of ILNs -with the following pathologic staging: pN0 73.5%, pN1 10.6%, pN2 6.9%, pN3 4.6%, and unknown 4.2%. Overall, 22.2% of patients who underwent ILN sampling were node positive. Binomial logistic regression analysis to determine statistically significant predictors of performance of ILN sampling identified that patients with higher comorbidities, lower pTstage, and those treated at non-academic hospitals were less likely to receive ILN sampling. On both univariate (Log Rank 11.56, p<0.01) and multivariate survival analysis, lack of ILN sampling was independently associated an increased risk of death (HR 1.72, p¼0.03).
CONCLUSIONS: Adherence to guidelines to perform ILN staging in high-risk, clinically node negative penile SCC in the United States is low; and significantly lower in community vs. academic hospitals. Omission of ILN sampling is independently associated with worse OS.
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